OriBase Pharma is an international contract research organization (CRO) specialized in the design and chemistry synthesis of kinase inhibitors, and dedicated to accelerating drug discovery processes.
Our mission is to deliver safe, drug-like novel molecular entities for clients’ projects through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.
Our technologies are based on a unique combination of rational in silico drug design & medicinal chemistry services.